North America Gamma Knife Market

North America Gamma Knife Market Size & Growth (2023 to 2028):

As per the research report, the size of the North America Gamma Knife Market is valued at USD 89.02 million in 2023 and estimated to be growing at a CAGR of 8.9%, to reach USD 136.35 million by 2028.

The North America Gamma Knife market is expected to be majorly driven by the factors such as the increasing incidence of chronic diseases such as cancer and neurological conditions across the region. Also, the growing demand for edge-cutting technologies to operate tumors detected in the spine, neck, and head is projected to fuel the market growth. 

As per WHO's data, Europe accounts for only one-eighth of the worldwide population yet accounts for almost one-quarter of all cancer cases, with approximately 3.7 million new patients each year. Most cancer deaths are caused by lung, breast, stomach, liver, colon, and breast cancer. Cancer is becoming more common as a result of lifestyle changes.  

The growing geriatric cancer population requires the development of non-invasive, accurate treatments with fewer adverse effects. According to the Neurological Alliance, one out of every six people has a neurological problem. As a result, a gamma knife can be used in meningioma surgery, stereotactic radiosurgery, and the treatment of numerous neurological disorders.

The rising methodical use of integrated imaging software to keep a constant track of dose delivery is expected to boost the market growth. 

The growing adoption of radiation devices and innovations to ensure minimal invasion and reduced postsurgical complications in surgery is estimated to support the market growth. 

Key market players focus on introducing innovations to provide advanced patient care, which is expected to uplift the market growth. In addition, key market strategies such as partnerships, mergers, and acquisitions are most likely to expand the European regional market growth.

In addition, Brainlab, a digital medical technology company, has announced the acquisition of Mint Medical GmbH. This medical technology company specializes in image reading and reporting software for clinical routine and research. Therefore, this acquisition is expected to help accelerate the automation of radiology reports through AI anatomical mapping and the creation of holistic data.

However, the high cost of the equipment is a major concern impeding the market growth. In addition, the lack of medical professionals long approval time associated with the new gamma knife system launch is expected to hinder the market growth. 

This research report on the North America Gamma Knife Market has been segmented and sub-segmented into the following categories:

By Disease Indication:

• Brain Metastasis
• Cancer
• Trigeminal Neuralgia
• AVM
• Others

By Country:

• U.S
• Canada
• Rest of North America

Geographically, the North American region holds the most significant share of the gamma knife market, and it is predicted to register a predominant share during the forecast period. 

The U.S Gamma Knife Market is likely to account for 20% of the gamma knife market in North America. During the forecast period, the demand for gamma knives will increase, with tier-1 firms accounting for 60-65 percent of the gamma knife market.

The Canada Gamma Knife Market is anticipated to witness a significant share due to the growing population, government insurance plans for radiotherapy, and supportive government policies. In addition, factors such as the high prevalence of cancer, neurological disorders, technological advancements, and growing healthcare expenditure propel market growth. 

The proliferation of brain tumors, growing usage of accurate and efficient integrated imaging software, and improving the healthcare sector contribute to market growth.

KEY MARKET PLAYERS

Companies playing a dominant role in the North America Gamma Knife Market profiled in this report are Varian Medical Systems, Elekta AB, Cyber Medical Corporation Ltd., Huiheng Medical Inc., Masep Infini North America, Inc., Hokai, Nordion Inc., ET Medical Group, and American Shared Hospital Services among others.,